Variant report

Variant	nsv975508
Chromosome Location	chr12:66430304-66435114
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	BCL3	chr12:66431944-66432260	GM12878	blood:	n/a	n/a
2	CHD2	chr12:66430243-66430426	Hela-S3	cervix:	n/a	n/a
3	CTCF	chr12:66430240-66430390	HRPEpiC	eye:	n/a	n/a
4	CTCF	chr12:66434618-66434663	LNCaP	prostate:	n/a	n/a
5	CTCF	chr12:66430040-66430330	HAc	cerebellar:	n/a	chr12:66430156-66430177
6	CTCF	chr12:66430034-66430306	IMR90	lung:	n/a	chr12:66430156-66430177
7	CTCF	chr12:66430180-66430330	HMF	breast:	n/a	n/a
8	E2F4	chr12:66430149-66430378	MCF10A-Er-Src	breast:	n/a	n/a
9	E2F4	chr12:66431955-66432149	MCF10A-Er-Src	breast:	n/a	n/a
10	EP300	chr12:66429903-66430864	ECC-1	luminal epithelium:	n/a	chr12:66430240-66430254
11	EP300	chr12:66430077-66430498	SK-N-SH_RA	brain:	n/a	chr12:66430240-66430254
12	EP300	chr12:66430012-66430514	SK-N-SH_RA	brain:	n/a	chr12:66430240-66430254
13	EP300	chr12:66428988-66430752	SK-N-SH	brain:	n/a	chr12:66429463-66429477 chr12:66430240-66430254 chr12:66429720-66429734
14	EP300	chr12:66429802-66430720	SK-N-SH	brain:	n/a	chr12:66430240-66430254
15	FOS	chr12:66430116-66430656	MCF10A-Er-Src	breast:	n/a	n/a
16	FOS	chr12:66430146-66430625	MCF10A-Er-Src	breast:	n/a	n/a
17	FOS	chr12:66430079-66430622	MCF10A-Er-Src	breast:	n/a	n/a
18	FOS	chr12:66430141-66430451	MCF10A-Er-Src	breast:	n/a	n/a
19	FOSL2	chr12:66430168-66430427	A549	lung:	n/a	n/a
20	FOSL2	chr12:66430035-66430540	A549	lung:	n/a	n/a
21	FOSL2	chr12:66429877-66430664	SK-N-SH	brain:	n/a	n/a
22	FOSL2	chr12:66430098-66430507	SK-N-SH	brain:	n/a	n/a
23	FOXA1	chr12:66430137-66430449	ECC-1	luminal epithelium:	n/a	n/a
24	FOXA2	chr12:66430075-66430456	A549	lung:	n/a	n/a
25	GATA3	chr12:66429844-66430695	SK-N-SH	brain:	n/a	n/a
26	GATA3	chr12:66429909-66430717	SK-N-SH	brain:	n/a	n/a
27	JUN	chr12:66430110-66430446	HUVEC	blood vessel:	n/a	n/a
28	JUND	chr12:66429917-66430654	SK-N-SH	brain:	n/a	n/a
29	JUND	chr12:66429983-66430766	SK-N-SH	brain:	n/a	n/a
30	JUND	chr12:66429982-66430718	SK-N-SH	brain:	n/a	n/a
31	MAX	chr12:66430011-66430617	SK-N-SH	brain:	n/a	n/a
32	MAX	chr12:66433791-66434123	NB4	blood:	n/a	chr12:66433935-66433945
33	MAX	chr12:66430034-66430659	SK-N-SH	brain:	n/a	n/a
34	MAZ	chr12:66429968-66430684	IMR90	lung:	n/a	n/a
35	MAZ	chr12:66430224-66430343	Hela-S3	cervix:	n/a	n/a
36	MEF2A	chr12:66429764-66430657	SK-N-SH	brain:	n/a	chr12:66430235-66430246 chr12:66429821-66429842 chr12:66430234-66430248 chr12:66430229-66430250 chr12:66430229-66430250 chr12:66429824-66429835
37	MEF2A	chr12:66429098-66430715	SK-N-SH	brain:	n/a	chr12:66430235-66430246 chr12:66429821-66429842 chr12:66430234-66430248 chr12:66430229-66430250 chr12:66429313-66429321 chr12:66430229-66430250 chr12:66429824-66429835
38	MYC	chr12:66430150-66430483	MCF10A-Er-Src	breast:	n/a	n/a
39	MYC	chr12:66430150-66430552	MCF10A-Er-Src	breast:	n/a	n/a
40	NFIC	chr12:66429929-66430615	SK-N-SH	brain:	n/a	n/a
41	NFIC	chr12:66429955-66430695	ECC-1	luminal epithelium:	n/a	n/a
42	NFIC	chr12:66428962-66430662	SK-N-SH	brain:	n/a	chr12:66429370-66429387 chr12:66429370-66429386
43	NR3C1	chr12:66430080-66430453	ECC-1	luminal epithelium:	n/a	n/a
44	NR3C1	chr12:66430072-66430503	ECC-1	luminal epithelium:	n/a	n/a
45	PBX3	chr12:66429919-66430686	SK-N-SH	brain:	n/a	n/a
46	PBX3	chr12:66429962-66430710	SK-N-SH	brain:	n/a	n/a
47	POLR2A	chr12:66430016-66430560	U87	brain:	n/a	n/a
48	POLR2A	chr12:66429995-66430610	SK-N-SH	brain:	n/a	n/a
49	POLR2A	chr12:66430189-66430572	SK-N-SH	brain:	n/a	n/a
50	POLR2A	chr12:66429983-66430393	HUVEC	blood vessel:	n/a	n/a

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr12:66430294-66430344	AG04450	lung:	fetal
2	chr12:66430294-66430344	HCT-116	colon:	n/a
3	chr12:66430294-66430344	HIPEpiC	eye:	n/a
4	chr12:66430294-66430344	HMEC	breast:	n/a
5	chr12:66430294-66430344	AoSMC	blood vessel:	n/a
6	chr12:66430294-66430344	GM19239	blood:	n/a
7	chr12:66430294-66430344	GM12878	blood:	n/a
8	chr12:66430294-66430344	GM12891	blood:	n/a
9	chr12:66430294-66430344	Caco-2	colon:	n/a
10	chr12:66430294-66430344	K562	blood:	n/a
11	chr12:66430294-66430344	HCF	heart:	n/a
12	chr12:66430294-66430344	HPAEpiC	pulmonary alveolar:	n/a
13	chr12:66430294-66430344	U87	brain:	n/a
14	chr12:66430294-66430344	SK-N-SH	brain:	n/a
15	chr12:66430294-66430344	T-47D	breast:	n/a
16	chr12:66430294-66430344	HCM	heart:	n/a
17	chr12:66430294-66430344	A549	lung:	n/a
18	chr12:66430294-66430344	MCF-7	breast:	n/a
19	chr12:66430294-66430344	Jurkat	blood:	n/a
20	chr12:66430294-66430344	ProgFib	skin:	n/a
21	chr12:66430294-66430344	NHBE	bronchial:	n/a
22	chr12:66430294-66430344	HUVEC	blood vessel:	n/a
23	chr12:66430294-66430344	HEK293	kidney:	embryo
24	chr12:66430294-66430344	CMK	blood:	n/a
25	chr12:66430294-66430344	AG04449	skin:	fetal
26	chr12:66430294-66430344	SAEC	small airway:	n/a
27	chr12:66430294-66430344	AG10803	skin:	n/a
28	chr12:66430294-66430344	Hepatocyte	liver:	n/a
29	chr12:66430294-66430344	IMR90	lung:	fetal
30	chr12:66430294-66430344	HRPEpiC	eye:	n/a
31	chr12:66430294-66430344	NB4	blood:	n/a
32	chr12:66430294-66430344	HL-60	blood:	n/a
33	chr12:66430294-66430344	H1-hESC	embryonic stem cell:	embryo
34	chr12:66430294-66430344	MCF10A-Er-Src	breast:	n/a
35	chr12:66430294-66430344	PANC-1	pancreas:	n/a
36	chr12:66430294-66430344	NH-A	brain:	n/a
37	chr12:66430294-66430344	HRCEpiC	kidney:	n/a
38	chr12:66430294-66430344	RPTEC	kidney:	n/a
39	chr12:66430294-66430344	AG09319	gingival:	n/a
40	chr12:66430294-66430344	ovcar-3	ovarian:	n/a
41	chr12:66430294-66430344	SK-N-MC	brain:	n/a
42	chr12:66430294-66430344	HEEpiC	esophagus:	n/a
43	chr12:66430294-66430344	ECC-1	luminal epithelium:	n/a
44	chr12:66430294-66430344	SKMC	muscle:	n/a
45	chr12:66430294-66430344	HRE	kidney:	n/a
46	chr12:66430294-66430344	NT2-D1	testis:	n/a
47	chr12:66430294-66430344	PrEC	prostate:	n/a
48	chr12:66430294-66430344	AG09309	skin:	n/a
49	chr12:66430294-66430344	LNCaP	prostate:	n/a
50	chr12:66430294-66430344	NHDF-neo	bronchial:	n/a

No.	Distal block	Cell Line	Cell type	Cell Stage
1	chr12:66429593..66431414-chr12:66432711..66435536,2	K562	blood:

Variant related genes	Relation type
ENSG00000213343	TF binding region
ENSG00000213343	CpG island
ENSG00000213343	chromatin interactions

Extended variants
information (count: 190 )
Associated
traits (count: 79 )

Variant overlapped rSNPs/rCNVs (count:190 , 50 per page) page: 1 2 3 4

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs569456347	chr12:66430314-66430315	Enhancers	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
2	rs575593680	chr12:66430318-66430319	Enhancers	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
3	rs4130827	chr12:66430452-66430453	Enhancers	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
4	rs564277086	chr12:66430461-66430462	Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
5	rs566408725	chr12:66430505-66430506	Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
6	rs532886214	chr12:66430539-66430540	Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
7	rs117035789	chr12:66430593-66430594	Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
8	rs114264876	chr12:66430595-66430596	Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
9	rs200106071	chr12:66430628-66430629	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
10	rs143901681	chr12:66430642-66430643	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
11	rs548556208	chr12:66430647-66430648	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
12	rs568430382	chr12:66430693-66430694	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
13	rs537321391	chr12:66430710-66430711	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
14	rs372562844	chr12:66430715-66430716	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
15	rs374886226	chr12:66430783-66430784	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
16	rs186596971	chr12:66430796-66430797	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
17	rs539635802	chr12:66430820-66430821	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
18	rs11830969	chr12:66430847-66430848	Enhancers Weak transcription	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
19	rs573351787	chr12:66430854-66430855	Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
20	rs190847561	chr12:66430868-66430869	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
21	rs555762909	chr12:66430881-66430882	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
22	rs555390481	chr12:66430883-66430884	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
23	rs552738249	chr12:66430898-66430899	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
24	rs116802683	chr12:66430929-66430930	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
25	rs144304930	chr12:66430960-66430961	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
26	rs538628861	chr12:66430968-66430969	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
27	rs540033048	chr12:66430973-66430974	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
28	rs559851686	chr12:66430981-66430982	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
29	rs148708823	chr12:66431001-66431002	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
30	rs548592127	chr12:66431029-66431030	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
31	rs369523020	chr12:66431061-66431062	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
32	rs142285544	chr12:66431082-66431083	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
33	rs183068997	chr12:66431096-66431097	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
34	rs531120402	chr12:66431103-66431104	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
35	rs371439419	chr12:66431113-66431114	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
36	rs551296956	chr12:66431116-66431117	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
37	rs113572043	chr12:66431178-66431179	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
38	rs540051653	chr12:66431199-66431200	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
39	rs139763588	chr12:66431205-66431206	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
40	rs566984895	chr12:66431223-66431224	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
41	rs35999636	chr12:66431233-66431234	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
42	rs535922956	chr12:66431274-66431275	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
43	rs117306974	chr12:66431280-66431281	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
44	rs569232052	chr12:66431285-66431286	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
45	rs185963620	chr12:66431301-66431302	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
46	rs190336657	chr12:66431305-66431306	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
47	rs201421294	chr12:66431329-66431330	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
48	rs577845965	chr12:66431348-66431349	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
49	rs540438344	chr12:66431359-66431360	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
50	rs553523936	chr12:66431423-66431424	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:79)

Disease	PMID	Source
Wilms tumour	21544195	CNVD
Esophageal cancer	21851588	CNVD
Lung cancer	20668451	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Ewing''s sarcoma	21437220	CNVD
Testicular germ cell tumor	18059402	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Medulloblastoma	21979893	CNVD
Malaria	21533027	CNVD
Chronic lymphocytic leukemia	22228453	CNVD
Basal cell lymphoma	17053054	CNVD
Chronic lymphocytic leukemia	21670202	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Autism	22495311	CNVD
Neurodevelopmental disorder	22521361	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Renal cell carcinoma	18194544	CNVD
Breast cancer	21949216	CNVD
Carcinoma ex pleomorphic adenoma	18828159	CNVD
Acute myeloid leukemia	16864856	CNVD
Cancer	21637783	CNVD
Glioblastoma multiforme	21080181	CNVD
Renal cell carcinoma	19461508	CNVD
Burkitt''s lymphoma	18698080	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	19960244	CNVD
Gastrointestinal stromal cancer	20470368	CNVD
Adenoid cystic carcinoma	17372589	CNVD
Lung cancer	18438408	CNVD
Breast cancer	17899364	CNVD
Colorectal cancer	16272173	CNVD
Glioblastoma multiforme	17387387	CNVD
liposarcomas	17372913	CNVD
Non-small cell lung cancer	24170126	CNVD
Cancer	16751803	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Breast cancer	21785460	CNVD
small cell lung cancer	20016488	CNVD
Melanoma	18172304	CNVD
Glioblastoma multiforme	21390271	CNVD
Cancer	20164919	CNVD
Leukemia	18628472	CNVD
Fibroblasts	20926602	CNVD
Metanephric adenoma	20802469	CNVD
Follicular lymphoma	18703704	CNVD
Acute myeloid leukemia	21251322	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Gastrointestinal stromal cancer	20877625	CNVD
Lung cancer	16773561	CNVD
Primary mediastinal b-cell lymphoma	17728785	CNVD
Mental retardation	17220210	CNVD
Osteopoikilosis	17220210	CNVD
short stature	17220210	CNVD
Burkitt''s lymphoma	20823134	CNVD
abnormal development	18461090	CNVD
Prostate cancer	18632612	CNVD
Ovarian neoplasms	16753589	CNVD
High-grade prostatic intraepithelial neoplasia	16573809	CNVD
Breast cancer	16620391	CNVD
Neuroticism	17667963	CNVD
Breast cancer	21364760	CNVD
Urothelial cell carcinoma	18451213	CNVD
Breast cancer	22048815	CNVD
Congenital anomalies of the kidney and urinary tract	21113617	CNVD
Glioblastoma multiforme	22291905	CNVD
Glioblastoma multiforme	19435819	CNVD
Myelofibrosis	22110671	CNVD
Myxofibrosarcoma	16751306	CNVD
Diffuse large b-cell lymphoma	18287131	CNVD
Lung cancer	17925434	CNVD
Myeloproliferative neoplasm	20015882	CNVD
Disease	21505450	CNVD
craniofacial dysmorphism	21918468	CNVD

Chromatin state (count:52 , 50 per page) page: 1 2

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr12:66428800-66431000	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
2	chr12:66429000-66430800	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
3	chr12:66429000-66430800	Enhancers	Osteobl	bone
4	chr12:66429000-66431000	Enhancers	Muscle Satellite Cultured Cells	--
5	chr12:66429000-66431000	Enhancers	NHLF	lung
6	chr12:66429200-66430800	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
7	chr12:66429200-66430800	Enhancers	HUVEC	blood vessel
8	chr12:66429200-66431000	Enhancers	HMEC	breast
9	chr12:66429200-66431000	Enhancers	HSMM	muscle
10	chr12:66429200-66431000	Enhancers	NHDF-Ad	bronchial
11	chr12:66429200-66431800	Enhancers	NHEK	skin
12	chr12:66429400-66430600	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
13	chr12:66429400-66430600	Enhancers	Foreskin Fibroblast Primary Cells skin01	Skin
14	chr12:66429400-66430600	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
15	chr12:66429400-66430800	Enhancers	Fetal Adrenal Gland	Adrenal Gland
16	chr12:66429400-66431000	Enhancers	Fetal Heart	heart
17	chr12:66429400-66431200	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
18	chr12:66429400-66432000	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
19	chr12:66429600-66430600	Enhancers	Foreskin Fibroblast Primary Cells skin02	Skin
20	chr12:66429600-66430800	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
21	chr12:66429600-66430800	Enhancers	Stomach Smooth Muscle	stomach
22	chr12:66429600-66430800	Enhancers	HSMMtube	muscle
23	chr12:66429800-66430600	Enhancers	Fetal Stomach	stomach
24	chr12:66429800-66430600	Enhancers	A549	lung
25	chr12:66429800-66431000	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
26	chr12:66430000-66430600	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
27	chr12:66430000-66430600	Enhancers	Colon Smooth Muscle	Colon
28	chr12:66430000-66430600	Enhancers	Fetal Muscle Leg	muscle
29	chr12:66430000-66430600	Enhancers	Left Ventricle	heart
30	chr12:66430000-66430600	Enhancers	Psoas Muscle	Psoas
31	chr12:66430000-66430600	Enhancers	HepG2	liver
32	chr12:66430000-66430800	Enhancers	NH-A	brain
33	chr12:66430200-66430600	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
34	chr12:66430400-66430600	Enhancers	Skeletal Muscle Male	skeletal muscle
35	chr12:66430600-66431400	Weak transcription	Foreskin Fibroblast Primary Cells skin01	Skin
36	chr12:66430600-66433600	Weak transcription	HepG2	liver
37	chr12:66430600-66438000	Weak transcription	Foreskin Keratinocyte Primary Cells skin03	Skin
38	chr12:66430800-66432600	Weak transcription	Fetal Adrenal Gland	Adrenal Gland
39	chr12:66430800-66438200	Weak transcription	NH-A	brain
40	chr12:66431000-66431400	Weak transcription	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
41	chr12:66431400-66431600	Enhancers	Foreskin Fibroblast Primary Cells skin01	Skin
42	chr12:66431400-66432000	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
43	chr12:66431600-66438000	Weak transcription	Foreskin Fibroblast Primary Cells skin01	Skin
44	chr12:66432000-66432200	Weak transcription	Foreskin Keratinocyte Primary Cells skin02	Skin
45	chr12:66432000-66436200	Weak transcription	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
46	chr12:66432600-66432800	Enhancers	GM12878-XiMat	blood
47	chr12:66432800-66435000	Weak transcription	GM12878-XiMat	blood
48	chr12:66433600-66434800	Enhancers	HepG2	liver
49	chr12:66433800-66434200	Enhancers	Primary hematopoietic stem cells short term culture	blood
50	chr12:66434600-66437200	Weak transcription	Fetal Adrenal Gland	Adrenal Gland

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links